Benitec appoints new CEO
This article was originally published in Scrip
Dr Peter French has been appointed CEO of the Australian venture Benitec, effective immediately. He was formerly the chief scientific officer of the Melbourne-based RNAi technology company and succeeds Sue MacLeman. Benitec has a number of active therapeutic research programmes based on gene silencing approaches, including in hepatitis B, HIV/AIDS and lung cancer.